
Retrotope
Retrotope is developing a pipeline of proprietary therapeutics designed to treat degenerative disease by down-regulating LPO in order to protect against cellular degeneration.
$20M Series B+ ·
Source: startupintros.com
Latest round on record: Series B+, August 2021, amount undisclosed.
All 2 rounds ↓Signals
Retrotope | 586 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | startupintros.com | |
| Series B+ | $20M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
MS
Mikhail S. Shchepinov Founder and CSOsource: retrotope.com
Companies like Retrotope
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
TTribune Therapeutics ABSeries A · Mar 2025
MModel Medicines$4.1M · Nov 2021
BBreye Therapeutics$76.65M Series A · Sep 2026
CCellaritySeries B+ · Nov 2024
PPretzel TherapeuticsSeries A · Sep 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/retrotope (get a free API key).